Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum quinidine levels after administration of three different quinidine preparations.

× No keyword cloud information.

23 in total

1. A METHOD FOR RELEASE RATE DETERMINATION FROM SUSTAINED-RELEASE TABLETS.

Authors: J SJOEGREN; M ERVIK
Journal: Acta Pharm Suec Date: 1964-12

2. ANTIARRHYTHMIC DRUGS. II. CLINICAL USE OF QUINIDINE.

Authors: A F LYON; A C DEGRAFF
Journal: Am Heart J Date: 1965-06 Impact factor: 4.749

3. New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge.

Authors: B LOWN; R AMARASINGHAM; J NEUMAN
Journal: JAMA Date: 1962-11-03 Impact factor: 56.272

4. Factors influencing conversion of chronic atrial fibrillation with special reference to serum quinidine concentration.

Authors: R E BALL; M SOKOLOW
Journal: Circulation Date: 1956-10 Impact factor: 29.690

5. The basis of quinidine therapy.

Authors: W D LOVE
Journal: Am J Med Sci Date: 1955-01 Impact factor: 2.378

6. Experiences with the photofluorometric determination of quinidine in blood.

Authors: A L EDGAR; M SOKOLOW
Journal: J Lab Clin Med Date: 1950-09

7. [A new anti-arrhythmic agent: a prolonged-action derivative of quinidine].

Authors: H Warembourg; G Ducloux
Journal: Lille Med Date: 1971-01

8. Comparative antiarrhythmic effects of intravenously administered lidocaine and procainamide and orally administered quinidine.

Authors: M L Schwartz; N C Webb; B G Covino; E M Finck; B Haider
Journal: Am J Cardiol Date: 1970-11 Impact factor: 2.778

9. [Prevention of rhythm disorders by a new quinidine salt with sustained-action: study of quinidinemia (apropos of 45 cases)].

Authors: M Salvador; J M Fauvel; J P Lesbre; F Galinier
Journal: Arch Mal Coeur Vaiss Date: 1971-05

10. Quinidine concentration in serum. The stability during maintained treatment with two different types of delayed absorption tablets.

Authors: E M Ditlefsen; C Bjerkelund
Journal: Acta Med Scand Date: 1966-11

5 in total

1. Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models.

Authors: Herbert M Himmel; Alexandra Bussek; Michael Hoffmann; Rolf Beckmann; Horst Lohmann; Matthias Schmidt; Erich Wettwer
Journal: Br J Pharmacol Date: 2012-05 Impact factor: 8.739

2. Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.

Authors: G M Frigo; E Perucca; M Teggia-Droghi; G Gatti; A Mussini; J Salerno
Journal: Br J Clin Pharmacol Date: 1977-08 Impact factor: 4.335

3. Dose-dependence of the pharmacokinetics of quinidine.

Authors: P Bolme; U Otto
Journal: Eur J Clin Pharmacol Date: 1977-08-17 Impact factor: 2.953

Review 4. Clinical pharmacokinetics of quinidine.

Authors: H R Ochs; D J Greenblatt; E Woo
Journal: Clin Pharmacokinet Date: 1980 Mar-Apr Impact factor: 6.447

5. Quinidine dosage, with special reference to an oral loading dose schedule.

Authors: P Collste; R Nordlander
Journal: Br J Clin Pharmacol Date: 1979-03 Impact factor: 4.335

5 in total